fepblue glp 1 2025 GLP-1 trends 2025: real-world data, patient outcomes & future therapies BCBS Dropping Anti-Obesity GLP-1s from

The diagrams in a , e and h were created using BioRender

Portfolio assessment: Identifying where volume pressure is structural and where premium repositioning is viable Consumer and market research: Combining proprietary survey data, transaction data and industry expertise to map shifting demand Growth strategy: Build a view of categories, formats and consumer segments offering the most definitive path to growth Business forecast support: Developing investment and growth plans aligned to the evolution of consumers and core categories Those that move now, through honest portfolio reviews, nutrition-aligned innovation, and communications that speak to the health-conscious consumer, will be far better positioned for a market that has already begun to change around them

& Hamel, L

Do not stop the medication cold turkey, as it may cause your blood sugar to increase

Post-Workout Recovery Preventing muscle loss while transitioning off medication

Note: Your data belongs to you